- Citations, last 5 years
- 2 184
- Works, last 5 years
- 118
- h-index
- 156
- Scientists listed
- 0
- Grants since 2016
- 11
Grants received
2024 · research · iPSC Phenotyping Environmental Exposure Program
Establishing a Proof-of-concept, Automated Platform for Studying the Interactions of Genetic and Environment-based Toxicity in Human Cell Models of Parkinson’s Disease
Gist Croft · New York Stem Cell Foundation · funded by Michael J. Fox Foundation for Parkinson's Research
2019–2022 · research · R21
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections
Laura Andres-Martin · New York Stem Cell Foundation · funded by National Institutes of Health
2019–2021 · research · R21
Investigating the biology of human neurotoxic reactive astrocytes using induced pluripotent stem cells
Valentina Fossati · New York Stem Cell Foundation · funded by National Institutes of Health
2019–2022 · research · R21
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections
Laura Andres-Martin · New York Stem Cell Foundation · funded by National Institutes of Health
2019–2022 · research · R21
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections
Laura Andres-Martin · New York Stem Cell Foundation · funded by National Institutes of Health
2018–2025 · research · R01
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
Valentina Fossati · New York Stem Cell Foundation · funded by National Institutes of Health
2018–2022 · contract · N01
THE PURPOSE OF THIS MODIFICATION IS TO CREATE ISOGENIC CELL CONTROL LINES FOR THE LINES CURRENTLY BEING CREATED.
Scott Noggle · New York Stem Cell Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
Valentina Fossati · New York Stem Cell Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
Valentina Fossati · New York Stem Cell Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
Valentina Fossati · New York Stem Cell Foundation · funded by National Institutes of Health
2018–2023 · research · R01
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease
Valentina Fossati · New York Stem Cell Foundation · funded by National Institutes of Health